These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 12775126)
1. Do leukotriene receptor antagonists have a place in pharmacotherapy of allergic rhinitis? Nathan RA Ann Allergy Asthma Immunol; 2003 May; 90(5):466-8. PubMed ID: 12775126 [No Abstract] [Full Text] [Related]
2. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135 [TBL] [Abstract][Full Text] [Related]
3. Leukotriene receptor antagonists are not as effective as intranasal corticosteroids for managing nighttime symptoms of allergic rhinitis. Nathan RA J Allergy Clin Immunol; 2005 Aug; 116(2):463-4. PubMed ID: 16083809 [No Abstract] [Full Text] [Related]
4. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. Pinar E; Eryigit O; Oncel S; Calli C; Yilmaz O; Yuksel H Auris Nasus Larynx; 2008 Mar; 35(1):61-6. PubMed ID: 17826020 [TBL] [Abstract][Full Text] [Related]
6. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Yamamoto H; Yamada T; Sakashita M; Kubo S; Susuki D; Tokunaga T; Ogi K; Terasawa Y; Yamashita S; Kayano Y; Masada M; Kimura Y; Fujieda S Allergy Asthma Proc; 2012; 33(2):e17-22. PubMed ID: 22525385 [TBL] [Abstract][Full Text] [Related]
8. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428 [TBL] [Abstract][Full Text] [Related]
9. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis]. Jia MH; Chen XY; Zhang Y; Liao ZS Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264 [No Abstract] [Full Text] [Related]
10. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of montelukast add-on therapy in allergic rhinitis. Modgill V; Badyal DK; Verghese A Methods Find Exp Clin Pharmacol; 2010 Nov; 32(9):669-74. PubMed ID: 21225018 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion. Prenner B; Anolik R; Danzig M; Yao R Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427 [TBL] [Abstract][Full Text] [Related]
13. Montelukast (singulair) for allergic rhinitis. Med Lett Drugs Ther; 2003 Mar; 45(1152):21-2. PubMed ID: 12637892 [No Abstract] [Full Text] [Related]
14. [Asthma patients with allergic rhinitis, To treat airways as a whole!]. MMW Fortschr Med; 2005 Feb; 147(8):57. PubMed ID: 18437863 [No Abstract] [Full Text] [Related]
15. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Nayak AS; Philip G; Lu S; Malice MP; Reiss TF; Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367 [TBL] [Abstract][Full Text] [Related]
16. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172 [TBL] [Abstract][Full Text] [Related]
17. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis. Prenner BM; Lu S; Danzig MR Allergy Asthma Proc; 2010; 31(6):493-8. PubMed ID: 21708061 [TBL] [Abstract][Full Text] [Related]
20. Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently. Keith P; Lee LA J Allergy Clin Immunol; 2011 Jan; 127(1):288-9; author reply 289. PubMed ID: 21047674 [No Abstract] [Full Text] [Related] [Next] [New Search]